IDEAYA Biosciences (NASDAQ: IDYA) is a public, clinical-stage precision medicine oncology company committed to the discovery, development, and commercialization of targeted therapeutics for patient populations with high unmet clinical needs. Our approach integrates extensive capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the therapies we are developing. We have developed an industry leading platform and pipeline in precision medicine by applying these capabilities across multiple approaches such as direct targeting of oncogenic pathways and synthetic lethality, which represents an emerging class of precision medicine targets. We believe this diversified approach will enable us to deliver the right medicine to the right patient to drive a more robust clinical response. IDEAYA has established strategic collaborations with GSK, Amgen, Pfizer, and Gilead but wholly-owns or controls its three most-advanced clinical programs and we are committed to building a best-in-industry organization to deliver our precision medicines to the people who need them.
When you're at IDEAYA, you will be in the midst of brilliant minds working on precision medicine therapies to help cancer patients. We are passionate and committed about being on the forefront of oncology medicine, which means we all have a high internal drive that is at the very core of every person at IDEAYA. We are inquisitive, ask deep questions, and are data-driven innovators who like to collaborate and use teamwork to move science forward. For more information, please see
www.ideayabio.com.
Notice to Agencies and Recruiters: All open positions and candidate activity are strictly managed through Human Resources. Please note that our policy is that recruiters do not contact employees/hiring managers directly to solicit business and/or present candidates. Submission of unsolicited resumes prior to an agreement set in place between the Human Resources Department and the recruiting agency will not create any implied obligation. Please note that failure to comply with this request will be a factor in developing a professional relationship with IDEAYA Bio. Inquiries regarding developing a recruiting relationship with us, may be directed to HR@ideayabio.com
Position Summary:
We are seeking an experienced Vice President, Market Access and Patient Services to build, lead and execute the market access and patient services strategy at IDEAYA. This leader will bring their extensive U.S. oncology experience to our initial product launch and will be responsible for developing U.S. and global market access and patient services strategies, with an initial focus on launch readiness and commercialization of our lead program darovasertib in Uveal Melanoma [UM]. The Vice President, Market Access and Patient Services is accountable for the company’s overall market access strategy, inclusive of product access launch plans, pricing, reimbursement, and contracting, as well as the design and implementation of patient services. The role is also responsible for building and managing the specialty distribution and trade operations functions. The preferred candidate will be an expert in U.S. market access dynamics and reimbursement complexities while having significant experience with health technology assessments, health economics, and a range of global markets. The role will also play a critical role in shaping and building a fit for purpose market access and patient services organization to input into clinical pipeline decisions and support future launches.
This is one of the first commercial hires for the company, and as a member of the commercial leadership team, this role will be integral in IDEAYA’s transition to a commercial stage biotechnology company.
This role reports to the Chief Commercial Officer and the role is based in IDEAYA’s South San Francisco, California office, with an expectation to be in office 4 days a week.